Acarix's Handheld CAD Device Proves Its Mettle As Frontline Test
Executive Summary
The latest clinical data on Acarix's handheld acoustic device, the CADScor system, backs the use of the technology as a frontline test for ruling out coronary artery disease in patients presenting with suspicious chest pain. Results from a multi-center trial showed CADScor achieved a 97% negative predictive value.